Showing results (161-170 of 2,441) with videos related to
Sort By:
Pageof 245
Diabetology & Metabolic Syndrome|May 8, 2020
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseKen Ohara, Takahiro Masuda, Masato Morinari, et al.Diabetology & Metabolic Syndrome|June 3, 2015
Insulin resistance by homeostasis model assessment in HIV-infected patients on highly active antiretroviral therapy: cross-sectional studyMiguel A Guillen, Fernando A Mejia, Jaime Villena, et al.Diabetology & Metabolic Syndrome|July 28, 2016
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetesTeruo Jojima, Takanori Tomotsune, Toshie Iijima, et al.Diabetology & Metabolic Syndrome|July 26, 2016
Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline dataBruno Linetzky, Brad Curtis, Gustavo Frechtel, et al.Diabetology & Metabolic Syndrome|May 6, 2020
Temporal trends of incident diabetes mellitus and subsequent outcomes in patients receiving kidney transplantation: a national cohort study in TaiwanHsuan Yeh, Chihung Lin, Yan-Rong Li, et al.Diabetology & Metabolic Syndrome|May 6, 2020
Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitusDong-Ni Yu, Lei Qiu, Shang-Yong Ning, et al.Diabetology & Metabolic Syndrome|June 2, 2020
Changes of circulating neuregulin 4 and its relationship with 25-hydroxy vitamin D and other diabetic vascular complications in patients with diabetic peripheral neuropathyPijun Yan, Zhihong Zhang, Ying Miao, et al.Diabetology & Metabolic Syndrome|June 2, 2020
Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetesWang-Shu Liu, Meng-Jie Tang, Tian-Li Xu, et al.Diabetology & Metabolic Syndrome|June 21, 2017
Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver diseaseTakashi Himoto, Koji Fujita, Takako Nomura, et al.Diabetology & Metabolic Syndrome|February 26, 2010
Buccal alterations in diabetes mellitusCarlos Antonio Negrato, Olinda TarziaPageof 245